Insulin Therapy Perspective

• Please Don't Use the Word 'Brittle' With Diabetes The word 'brittle' in the context of diabetes is unscientific, unhelpful, and potentially harmful, says Miriam E. Tucker, a Medscape contributing writer who lives with type 1 diabetes.
  Medscape Diabetes & Endocrinology, April 12, 2021
• The Omnipod 5 System: Trial Results From ENDO 2021   Find out why Dr Anne Peters was 'incredibly excited' to see data presented from the Omnipod 5 clinical trials.
  Medscape Diabetes & Endocrinology, April 02, 2021
• "Heart" of the New ADA Guidelines: Pharmacologic Approaches   Dr Anne Peters continues her overview of the ADA 2021 Standards of Care, focusing on the updates to pharmacologic management of glycemia.
  Medscape Diabetes & Endocrinology, January 07, 2021
• Key Changes to the 2021 ADA Standards of Care   Dr Anne Peters provides an overview of important changes to the first half of the ADA 2021 Standards of Care.
  Medscape Diabetes & Endocrinology, January 04, 2021
• Physicians of the Year 2020: Best and Worst Physicians and other healthcare workers around the world worked tirelessly on the front lines of the COVID-19 pandemic, and hundreds lost their lives as a result. However, with the good comes the bad.
  Medscape News Slideshows, December 18, 2020
• GLP-1 Receptor Agonists at EASD 2020: Poster Pearls Dr Akshay Jain shares his top poster picks on GLP-1 receptor agonists from this year's EASD virtual meeting.
  Medscape Diabetes & Endocrinology, December 11, 2020
• 3 Myths About Continuous Glucose Monitoring Continuous glucose monitoring may be one of the greatest advances in diabetes, so why are so few clinicians prescribing it?
  Medscape Diabetes & Endocrinology, November 03, 2020
• New Diabetes Guidelines: 'Treat to Mitigate' Dr Akshay Jain reviews the new position statement from Primary Care Diabetes Europe on the management of type 2 diabetes.
  Medscape Diabetes & Endocrinology, October 29, 2020
• What Is LADA and How Should We Treat It?   A new consensus statement on LADA, or latent autoimmune diabetes in the adult, attempts to define this perplexing disease and give guidance on management.
  Medscape Diabetes & Endocrinology, October 23, 2020
• Insulin Updates From EASD 2020   Dr Anne Peters discusses recent data presented at the EASD meeting on ultra rapid-acting and once-weekly insulins.
  Medscape Diabetes & Endocrinology, October 05, 2020
• 'Stop Boring Patients': Tips for Engaging Diabetes Education   Dr William Polonsky discusses ways for diabetes educators to be creative in personalizing content to improve retention for group-based diabetes education.
  Medscape Diabetes & Endocrinology, July 24, 2020
• CGM in Type 2 Diabetes: Invaluable or Too Expensive? Is the value of using CGM in people with type 2 diabetes worth the cost? Dr Akshay Jain comments on a debate from ADA 2020.
  Medscape Diabetes & Endocrinology, July 21, 2020
• ADA 2020 Read clinically focused news coverage of key developments from ADA 2020
  Medscape Diabetes & Endocrinology, June 08, 2020
• Managing Type 2 Diabetes as Patients Age: Age Considerations   Goals of diabetes management shift as patients age. Experts discuss the increased risk for hypoglycemia and the effect of comorbidities on diabetes treatment.
  Medscape TV, December 20, 2019
• Emergency Preparedness With Diabetes: Two Rules   Dr Anne Peters has two plans for making sure life-saving insulin and other necessities for diabetes are at the ready in case of evacuation or emergency.
  Medscape Diabetes & Endocrinology, December 09, 2019
• How About a Troubleshooting Guide for Patients? What would serve patients best would be a readily available checklist, says Dr Plotzker.
  Medscape Diabetes & Endocrinology, November 27, 2019
• Managing Type 2 Diabetes as Patients Age: Slowing Progression   In their effort to slow diabetes progression, experts emphasize a personalized approach and discuss initiation of insulin therapy as well as bariatric surgery.
  Medscape TV, November 07, 2019
• Top News From EASD 2019: Slideshow Support for early combination therapy in newly diagnosed type 2 diabetes and "stunning" benefits with dapagliflozin in heart failure featured prominently this year.
  Medscape News Slideshows, October 07, 2019
• Managing Type 2 Diabetes as Patients Age: All-in Regimen   Diabetes experts discuss strategies to help patients meet management goals and stress the importance of patient education to achieve treatment adherence.
  Medscape TV, October 01, 2019
• Spotlight on SGLT Inhibitors for Type 1 Diabetes: EASD 2019   The risks and benefits of SGLT inhibitor use in type 1 diabetes is a hot topic at EASD 2019, says Dr Danne.
  Medscape Diabetes & Endocrinology, September 25, 2019